No abstract available
MeSH terms
-
Angiogenesis Inhibitors / therapeutic use*
-
Chelating Agents / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Copper / metabolism*
-
Female
-
Humans
-
Mammography
-
Molecular Targeted Therapy*
-
Molybdenum / therapeutic use*
-
Triple Negative Breast Neoplasms / diagnostic imaging
-
Triple Negative Breast Neoplasms / drug therapy*
Substances
-
Angiogenesis Inhibitors
-
Chelating Agents
-
Copper
-
Molybdenum
-
tetrathiomolybdate